Topical Microbicides for Disease Prevention: Status and Challenges
Open Access
- 15 May 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (10) , 1290-1294
- https://doi.org/10.1086/374834
Abstract
As the human immunodeficiency virus and sexually transmitted disease epidemics advance relentlessly, it is clear that an armamentarium of therapeutic and preventive methods will be essential to their containment. Topical microbicides—self-administered prophylactic agents applied to the vagina or rectum in various formulations—could be a crucial addition to that necessary armamentarium. This article provides an update on the dramatically broadening array of approaches being pursued in microbicide research and development and identifies critical challenges to progress.Keywords
This publication has 8 references indexed in Scilit:
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialThe Lancet, 2002
- Effect of Nonoxynol-9 Gel on Urogenital Gonorrhea and Chlamydial InfectionJAMA, 2002
- Polyanionic (i.e., Polysulfonate) Dendrimers Can Inhibit the Replication of Human Immunodeficiency Virus by Interfering with Both Virus Adsorption and Later Steps (Reverse Transcriptase/Integrase) in the Virus Replicative CycleMolecular Pharmacology, 2000
- Innate antiviral defenses in body fluids and tissuesAntiviral Research, 2000
- Anal Sex Among HIV-Seronegative Women at High Risk of HIV ExposureJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infectionSexually Transmitted Infections, 1999
- Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention.American Journal of Public Health, 1998
- HIV/AIDS in Latin America and the CaribbeanAIDS, 1996